Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
SEC Accession No. 0001130319-07-000057
Filing Date
2007-02-06
Accepted
2007-02-06 17:25:43
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-10 o34618a1fv10za.htm F-10/A 347513
2 EXHIBIT 5.1 o34618a1exv5w1.htm EX-5.1 2031
3 EXHIBIT 5.2 o34618a1exv5w2.htm EX-5.2 2793
4 EXHIBIT 5.3 o34618a1exv5w3.htm EX-5.3 2365
5 GRAPHIC o34618a1o3461800.gif GRAPHIC 1920
6 GRAPHIC o34618a1o3461801.gif GRAPHIC 8884
  Complete submission text file 0001130319-07-000057.txt   371291
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10/A | Act: 33 | File No.: 333-140460 | Film No.: 07585418
SIC: 2834 Pharmaceutical Preparations